Gossamer Bio Investor Relations Material
Latest events
Collaboration with Chiesi Farmaceutici S.p.A. 2024
Gossamer Bio
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Gossamer Bio Inc
Access all reports
Gossamer Bio, Inc. is a U.S.-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in immunology, inflammation, and oncology. The company’s research pipeline targets diseases with unmet medical needs, including autoimmune disorders, inflammatory conditions, and cancer. Gossamer Bio leverages its scientific expertise to advance novel drug candidates through clinical trials, aiming to deliver effective treatment options for complex and chronic illnesses. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Gossamer Bio Inc
Collaboration with Chiesi Farmaceutici S.p.A. 2024
Gossamer Bio Inc
Corporate Presentation 2024
Gossamer Bio Inc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
GOSS
Country
🇺🇸 United States